In silico designing of a novel polyvalent multi-subunit peptide vaccine leveraging cross- immunity against human visceral & cutaneous leishmaniasis: An Immunoinformatics-based approach [PDF]
, 2022 Mainak Bhattacharjee +2 more
openalex +1 more source
An Overview of theLaboratory Diagnostic Procedures of Visceral Leishmaniasis (Kala-Azar)
Medical Laboratory Journal, 2013 Visceral leishmaniasis (Kala-azar) is a systemic infection disease that can be diagnosed by some invasive procedures such as splenic, liver biopsy or bone marrow aspiration, whichare determined as the gold standards for diagnosing of this disease.
M Fakhar, E Ahmad Pour
doaj
Distribution of putative male sex pheromones among Lutzomyia sandflies (Diptera: Psychodidae).
, 2002 Male Lutzomyia longipalpis produce terpene sex pheromones in glandular tissue underlying the cuticle. The pheromones are transmitted to the surface via cuticle-lined ducts (measuring 0.25 microm in diameter), each of which reaches the surface in the ...
Brazil, RP +6 more
core +1 more source
Natural history of a visceral leishmaniasis outbreak in highland Ethiopia [PDF]
, 2009 In May 2005, visceral leishmaniasis (VL) was recognized for the first time in Libo Kemken, Ethiopia, a highland region where only few cases had been reported before. We analyzed records of VL patients treated from May 25, 2005 to December 13, 2007 by the
Alvar, J +14 more
core +1 more source
A prime/boost DNA/Modified vaccinia virus Ankara vaccine expressing recombinant Leishmania DNA encoding TRYP is safe and immunogenic in outbred dogs, the reservoir of zoonotic visceral leishmaniasis [PDF]
Previous studies demonstrated safety, immunogenicity and efficacy of DNA/modified vaccinia virus Ankara (MVA) prime/boost vaccines expressing tryparedoxin peroxidase (TRYP) and Leishmania homologue of the mammalian receptor for activated C kinase (LACK ...
Alcami, Antonio +7 more
core +1 more source
Current issues in the treatment of visceral leishmaniasis. [PDF]
, 2001 Bryceson, A
core +1 more source
Przeglad epidemiologiczny, 2003 Leishmanioses are widespread in 88 countries of the tropical and subtropical zone, including regions of the Mediterranean Sea basin of Southern Europe. Actually, approximately 350 million of people live in Leishmania endemic areas and about 12 million of individuals are infected.
Jerzy, Stefaniak +3 more
openaire +1 more source
Immunity and immunosuppression in experimental visceral leishmaniasis
Brazilian Journal of Medical and Biological Research, 2004 Leishmaniasis is a disease caused by protozoa of the genus Leishmania, and visceral leishmaniasis is a form in which the inner organs are affected. Since knowledge about immunity in experimental visceral leishmaniasis is poor, we present here a review on
Goto H., Lindoso J.A.L.
doaj